DE3483973D1 - Hydroxypyridone und ihre pharmazeutischen zusammensetzungen. - Google Patents

Hydroxypyridone und ihre pharmazeutischen zusammensetzungen.

Info

Publication number
DE3483973D1
DE3483973D1 DE8484301881T DE3483973T DE3483973D1 DE 3483973 D1 DE3483973 D1 DE 3483973D1 DE 8484301881 T DE8484301881 T DE 8484301881T DE 3483973 T DE3483973 T DE 3483973T DE 3483973 D1 DE3483973 D1 DE 3483973D1
Authority
DE
Germany
Prior art keywords
hydroxypyridone
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8484301881T
Other languages
English (en)
Inventor
Robert Charles Hider
George Kontoghiorghes
Jack Silver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
National Research Development Corp UK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Development Corp UK filed Critical National Research Development Corp UK
Application granted granted Critical
Publication of DE3483973D1 publication Critical patent/DE3483973D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • External Artificial Organs (AREA)
DE8484301881T 1983-03-24 1984-03-20 Hydroxypyridone und ihre pharmazeutischen zusammensetzungen. Expired - Lifetime DE3483973D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838308054A GB8308054D0 (en) 1983-03-24 1983-03-24 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DE3483973D1 true DE3483973D1 (de) 1991-02-28

Family

ID=10540098

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3486441T Expired - Lifetime DE3486441T2 (de) 1983-03-24 1984-03-20 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen
DE8484301881T Expired - Lifetime DE3483973D1 (de) 1983-03-24 1984-03-20 Hydroxypyridone und ihre pharmazeutischen zusammensetzungen.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE3486441T Expired - Lifetime DE3486441T2 (de) 1983-03-24 1984-03-20 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen

Country Status (9)

Country Link
US (2) US4585780A (de)
EP (1) EP0120669B1 (de)
JP (2) JPH0672097B2 (de)
CY (1) CY1510A (de)
DE (2) DE3486441T2 (de)
GB (2) GB8308054D0 (de)
GR (1) GR81911B (de)
HK (1) HK37590A (de)
SG (1) SG71089G (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
US5089644A (en) * 1985-01-04 1992-02-18 Salutar Inc. Preparation of oxamine complexes
US4908371A (en) * 1987-11-10 1990-03-13 Ciba-Geigy Corporation Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload
EP0335745A1 (de) * 1988-03-31 1989-10-04 The Royal Free Hospital School Of Medicine Verfahren zur Herstellung von Pyridin-4-onen
GB8910521D0 (en) * 1989-05-08 1989-06-21 Nat Res Dev The stabilization of organic compounds
GB9002061D0 (en) * 1990-01-30 1990-03-28 Bannister Joseph V Iron assay
GB9100465D0 (en) * 1991-01-09 1991-02-20 Hider Robert C Pharmaceutical compositions
US5494935A (en) * 1992-01-17 1996-02-27 University Of Utah Research Foundation Methods for oral decorporation of metals
US5403862A (en) * 1992-01-17 1995-04-04 University Of Utah Research Foundation Method for oral decorporation of metals
GB9209078D0 (en) * 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions
GB9217099D0 (en) * 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
US5849587A (en) * 1995-06-09 1998-12-15 Cornell Research Foundation, Inc. Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
ES2230564T3 (es) 1995-06-10 2005-05-01 Vitra Pharmaceuticals Ltd. Compuestos ferricos, composiciones, metodos de fabricacion de estos y sus utilizacioneds.
JPH0925234A (ja) * 1995-07-12 1997-01-28 Wakunaga Pharmaceut Co Ltd 脳疾患改善剤
ATE299135T1 (de) * 1995-09-29 2005-07-15 Novartis Pharma Gmbh Hydroxypyridinone
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
GB9625638D0 (en) * 1996-12-10 1997-01-29 Cenes Ltd Therapeutic antioxidants for alzheimer's diease
US5882799A (en) * 1996-12-16 1999-03-16 Vernay Laboratories, Inc. Polymeric coupling agents for the adhesion of macromolecular materials and metal substrates
US6294152B1 (en) * 1999-01-11 2001-09-25 The University Of Toledo Iron(III) complexes as contrast agents for image enhancement in magnetic resonance imaging
US20030024913A1 (en) * 2002-04-15 2003-02-06 Downes Joseph P. Laser scanning method and system for marking articles such as printed circuit boards, integrated circuits and the like
IL135884A (en) * 2000-04-30 2005-08-31 Yissum Res Dev Co Method for measuring non-transferrin bound iron
WO2002024196A1 (en) * 2000-09-19 2002-03-28 Vitra Pharmaceuticals Limited Iron compositions
CN100515928C (zh) * 2000-12-22 2009-07-22 空气制品及化学品有限公司 包含氧化和络合化合物的组合物
GB0211500D0 (en) * 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
CA2504512A1 (en) 2002-10-30 2004-05-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Molecules and methods using same for measuring non-transferrin bound iron
EP1679962B1 (de) * 2003-10-20 2021-01-13 Framework Therapeutics, L.L.C. Zeolit-molekulare siebe für die entfernung von toxinen
NZ529657A (en) * 2003-11-20 2004-07-30 Apotex Inc Iron chelating cycloalkyl derivatives of 3-hydroxy-4-pyridinones
WO2005110399A2 (en) * 2004-04-29 2005-11-24 The Regents Of The University Of California Zinc-binding groups for metalloprotein inhibitors
EP1755586A2 (de) * 2004-04-29 2007-02-28 The Regents of the University of California Hydroxypyridinon-, hydroxypyridinethion-, pyron- und thiopyron-metalloproteinhemmer
CA2627529A1 (en) 2007-03-28 2008-09-28 Apotex Technologies Inc. Fluorinated derivatives of deferiprone
GB0803019D0 (en) * 2008-02-19 2008-03-26 Btg Int Ltd Fluorinated compounds
UA102254C2 (ru) 2008-04-25 2013-06-25 Апотекс Технолоджис Инк. Жидкий состав для деферипрона с приятным вкусом
EP2448922B1 (de) * 2009-07-03 2014-08-20 Apotex Technologies Inc. Fluorierte 3-hydroxypyridin-4-on-derivate
GB201007209D0 (en) 2010-04-29 2010-06-16 King S College London Compound
CN102190644B (zh) * 2011-03-31 2012-11-21 浙江大学 手性3-羟基吡啶-4-酮类衍生物及其合成和用途
WO2012137202A1 (en) 2011-04-05 2012-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
US20180338897A1 (en) * 2017-05-24 2018-11-29 New York University Oral compositions for reducing dental stains

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3016372A (en) * 1956-12-13 1962-01-09 Searle & Co Glycosides of the pyridone series
CH449011A (de) * 1965-04-29 1967-12-31 Geigy Ag J R Verfahren zur Herstellung von 2,3-Pyridindiol
AR207322A1 (es) * 1972-12-18 1976-09-30 Merck & Co Inc Procedimiento para preparar complejos de 4,4'-dinitrocarbanilidas con derivados de piridonas 2-y 4-substituidas pirimidin-2-y-6-/nas y tetrahidroquinolonas utiles para la prevencion y tratamiento da la coccidiosis
US3847927A (en) * 1972-12-20 1974-11-12 Dow Chemical Co Sulfur-containing hydroxypyridones
GB1455687A (en) * 1972-12-28 1976-11-17 Aspro Nicholas Ltd Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines
JPS5953261B2 (ja) * 1973-08-03 1984-12-24 明治製菓株式会社 ２（１ｈ）−ピリドン誘導体の製造法
IE40057B1 (en) * 1973-11-07 1979-02-28 Richardson Merrell Inc 4-oxo-1-pyridinyl penicillin and cephalosporin derivatives
GB1591642A (en) * 1977-03-03 1981-06-24 Ciba Geigy Ag Hydroxypyridone dyestuffs
US4131131A (en) * 1977-06-22 1978-12-26 Dayco Corporation Valve construction
DE3005069A1 (de) * 1980-02-11 1981-08-20 Cassella Ag, 6000 Frankfurt Pyridonderivate, ihre herstellung und ihre verwendung
GR78491B (de) * 1982-03-24 1984-09-27 Nat Res Dev
GB2118176B (en) * 1982-03-24 1985-12-04 Nat Res Dev Pharmaceutical compositions
GB2117766B (en) * 1982-03-24 1985-08-29 Nat Res Dev Pharmaceutical compositions
EP0094149B1 (de) * 1982-03-24 1986-09-10 National Research Development Corporation Pharmazeutische Zusammensetzungen, die Eisen-Komplexe von N-substituierten 3-Hydroxypyrid-2-on- oder -4-on-Derivaten enthalten
JPS59118792A (ja) * 1982-12-24 1984-07-09 Kyowa Hakko Kogyo Co Ltd セフエム化合物
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8325494D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
USRE34313E (en) * 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions

Also Published As

Publication number Publication date
US4585780A (en) 1986-04-29
USRE35948E (en) 1998-11-03
HK37590A (en) 1990-05-25
JPS59205361A (ja) 1984-11-20
EP0120669A3 (en) 1985-01-23
EP0120669A2 (de) 1984-10-03
GR81911B (de) 1984-12-12
DE3486441D1 (de) 1996-12-19
JPH0672097B2 (ja) 1994-09-14
GB8308054D0 (en) 1983-05-05
JPH0680637A (ja) 1994-03-22
GB2136807A (en) 1984-09-26
SG71089G (en) 1990-03-02
CY1510A (en) 1990-08-03
DE3486441T2 (de) 1997-05-07
GB8407181D0 (en) 1984-04-26
JPH0764815B2 (ja) 1995-07-12
GB2136807B (en) 1987-04-23
EP0120669B1 (de) 1991-01-23

Similar Documents

Publication Publication Date Title
DE3483973D1 (de) Hydroxypyridone und ihre pharmazeutischen zusammensetzungen.
FR2547727B1 (fr) Compositions pharmaceutiques
BR1100036A (pt) Composto e composição farmacêutica
DE3673000D1 (de) Aether-isonitrile und ihre radiomarkierten komplexe.
NZ210440A (en) N-acylcyclohexyl-1,2-diamine derivatives and pharmaceutical compositions
DE3871751D1 (de) Gelbildende organosiloxanzusammensetzungen und deren verwendung.
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
KR870700608A (ko) 아미노-살리실산 유도체 및 제약 조성물
DE3873797D1 (de) E-prostaglandine und ihre anti-ulcusanwendung.
DE3879811D1 (de) Pharmazeutische zusammensetzung und ihre verwendung.
NZ209064A (en) N 6 -diarylalkyl-adenosine derivatives and pharmaceutical compositions
DE3579730D1 (de) Eisen-3-hydroxypyron- oder 3-hydroxypyridon-komplexe und diese enthaltende pharmazeutische zusammensetzungen.
DE3583214D1 (de) 3-substituierte carbacephem- und cephemverbindungen und ihre pharmazeutischen zusammensetzungen.
DE3576341D1 (de) Deuteroporphyrinderivate und ihre salze.
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
FI872313A (fi) Farmaceutiska kompositioner.
FI883673A0 (fi) Farmaceutiska kompositioner.
IT8323396A0 (it) Antimuscarinica. composizione farmaceutica adattivita' sistemica anticolinesterasica, agonista-colinergica ed
IT8319958A0 (it) Composizioni farmaceutiche adattivita' antineoplastica.
IT8424159A0 (it) Composizioni farmaceutiche antitumorali e procedimento per laloro preparazione.
DK374988A (da) Tertiaere 2,5-dialkyl-3-phenylpiperidin-derivater med opiat-antagonistisk aktivitet og farmaceutiske kompositioner indeholdende forbindelserne
ATE27599T1 (de) Rooperol und dessen derivate.
PH19575A (en) Cephalosporing derivatives and pharmaceutical compositions thereof
IT8548964A0 (it) 8alfa-acilamminoergoline,loro preparazione e composizioni farmaceutiche che le contengono
MX11584A (es) Composiciones farmaceuticas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BRITISH TECHNOLOGY GROUP LTD., LONDON, GB